Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
Forge Biologics’ $120 Million Series B Financing
AppLovin’s IPO
Wilson Sonsini Goodrich & Rosati advised AppLovin on the deal while Fenwick & West LLP represented the underwriters. Simpson Thacher also advised on the deal. AppLovin...
Exodus Movement’s Rights Offering
Wilson Sonsini Goodrich & Rosati advised Exodus Movement, Inc. on the deal. Exodus Movement, Inc., the developer of the Exodus Wallet, a leading non-custodial cryptocurrency software...
Cricut’s IPO
Wilson Sonsini Goodrich & Rosati advised Cricut, Inc. on the deal. Cricut, Inc., the creative technology company that has brought a connected platform for making to...
VIZIO’s $257.2 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised VIZIO on the deal, while Davis Polk advised the representatives of the several underwriters. VIZIO announced the pricing of its...
Everlywell’s Acquisition of PWNHealth and Home Access Health Corporation
Wilson Sonsini Goodrich & Rosati advised Everlywell on the deal, while Choate represented PWNHealth. Everlywell, a leading digital health company, announced that it has acquired PWNHealth...
NightDragon Acquisition Corp.’s $345 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised NightDragon Acquisition Corp. on the deal, while Davis Polk advised the representative of the several underwriters. NightDragon Acquisition Corp. closed...
Arya Sciences Acquisition Corp III’s Merger with Nautilus Biotechnology
Wilson Sonsini Goodrich & Rosati, P.C. advised Nautilus Biotechnology, while Kirkland & Ellis LLP, working alongside Ogier, advised Arya III on the deal. Latham & Watkins...